These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 18042552)
1. Hepatic CTP:phosphocholine cytidylyltransferase-alpha is a critical predictor of plasma high density lipoprotein and very low density lipoprotein. Jacobs RL; Lingrell S; Zhao Y; Francis GA; Vance DE J Biol Chem; 2008 Jan; 283(4):2147-55. PubMed ID: 18042552 [TBL] [Abstract][Full Text] [Related]
2. Targeted deletion of hepatic CTP:phosphocholine cytidylyltransferase alpha in mice decreases plasma high density and very low density lipoproteins. Jacobs RL; Devlin C; Tabas I; Vance DE J Biol Chem; 2004 Nov; 279(45):47402-10. PubMed ID: 15331603 [TBL] [Abstract][Full Text] [Related]
3. Impaired phosphatidylcholine biosynthesis does not attenuate liver regeneration after 70% partial hepatectomy in hepatic CTP:phosphocholine cytidylyltransferase-α deficient mice. Ling J; Zhu LF; Vance DE; Jacobs RL Can J Physiol Pharmacol; 2012 Oct; 90(10):1403-12. PubMed ID: 23074967 [TBL] [Abstract][Full Text] [Related]
4. Hepatic deficiency of low density lipoprotein receptor-related protein-1 reduces high density lipoprotein secretion and plasma levels in mice. Basford JE; Wancata L; Hofmann SM; Silva RA; Davidson WS; Howles PN; Hui DY J Biol Chem; 2011 Apr; 286(15):13079-87. PubMed ID: 21343303 [TBL] [Abstract][Full Text] [Related]
5. Phosphatidylcholine protects against steatosis in mice but not non-alcoholic steatohepatitis. Niebergall LJ; Jacobs RL; Chaba T; Vance DE Biochim Biophys Acta; 2011 Dec; 1811(12):1177-85. PubMed ID: 21745592 [TBL] [Abstract][Full Text] [Related]
6. Macrophages deficient in CTP:Phosphocholine cytidylyltransferase-alpha are viable under normal culture conditions but are highly susceptible to free cholesterol-induced death. Molecular genetic evidence that the induction of phosphatidylcholine biosynthesis in free cholesterol-loaded macrophages is an adaptive response. Zhang D; Tang W; Yao PM; Yang C; Xie B; Jackowski S; Tabas I J Biol Chem; 2000 Nov; 275(45):35368-76. PubMed ID: 10944538 [TBL] [Abstract][Full Text] [Related]
7. Targeted deletion of hepatocyte ABCA1 leads to very low density lipoprotein triglyceride overproduction and low density lipoprotein hypercatabolism. Chung S; Timmins JM; Duong M; Degirolamo C; Rong S; Sawyer JK; Singaraja RR; Hayden MR; Maeda N; Rudel LL; Shelness GS; Parks JS J Biol Chem; 2010 Apr; 285(16):12197-209. PubMed ID: 20178985 [TBL] [Abstract][Full Text] [Related]
8. Abnormal phospholipid composition impairs HDL biogenesis and maturation in mice lacking Abca1. Francone OL; Subbaiah PV; van Tol A; Royer L; Haghpassand M Biochemistry; 2003 Jul; 42(28):8569-78. PubMed ID: 12859204 [TBL] [Abstract][Full Text] [Related]
9. Intestinal de novo phosphatidylcholine synthesis is required for dietary lipid absorption and metabolic homeostasis. Kennelly JP; van der Veen JN; Nelson RC; Leonard KA; Havinga R; Buteau J; Kuipers F; Jacobs RL J Lipid Res; 2018 Sep; 59(9):1695-1708. PubMed ID: 30007917 [TBL] [Abstract][Full Text] [Related]
10. Adiponectin deficiency suppresses ABCA1 expression and ApoA-I synthesis in the liver. Oku H; Matsuura F; Koseki M; Sandoval JC; Yuasa-Kawase M; Tsubakio-Yamamoto K; Masuda D; Maeda N; Ohama T; Ishigami M; Nishida M; Hirano K; Kihara S; Hori M; Shimomura I; Yamashita S FEBS Lett; 2007 Oct; 581(26):5029-33. PubMed ID: 17936760 [TBL] [Abstract][Full Text] [Related]
11. Sp1 is a co-activator with Ets-1, and Net is an important repressor of the transcription of CTP:phosphocholine cytidylyltransferase alpha. Sugimoto H; Okamura K; Sugimoto S; Satou M; Hattori T; Vance DE; Izumi T J Biol Chem; 2005 Dec; 280(49):40857-66. PubMed ID: 16157598 [TBL] [Abstract][Full Text] [Related]
12. Pim-1L Protects Cell Surface-Resident ABCA1 From Lysosomal Degradation in Hepatocytes and Thereby Regulates Plasma High-Density Lipoprotein Level. Katsube A; Hayashi H; Kusuhara H Arterioscler Thromb Vasc Biol; 2016 Dec; 36(12):2304-2314. PubMed ID: 27765770 [TBL] [Abstract][Full Text] [Related]
13. Liver-specific phospholipid transfer protein deficiency reduces high-density lipoprotein and non-high-density lipoprotein production in mice. Yazdanyar A; Quan W; Jin W; Jiang XC Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2058-64. PubMed ID: 23846500 [TBL] [Abstract][Full Text] [Related]
14. Involvement of CTP:phosphocholine cytidylyltransferase-β2 in axonal phosphatidylcholine synthesis and branching of neurons. Strakova J; Demizieux L; Campenot RB; Vance DE; Vance JE Biochim Biophys Acta; 2011 Oct; 1811(10):617-25. PubMed ID: 21736954 [TBL] [Abstract][Full Text] [Related]
15. Intracellular lipidation of newly synthesized apolipoprotein A-I in primary murine hepatocytes. Maric J; Kiss RS; Franklin V; Marcel YL J Biol Chem; 2005 Dec; 280(48):39942-9. PubMed ID: 16204232 [TBL] [Abstract][Full Text] [Related]
16. Hepatic ABCA1 and VLDL triglyceride production. Liu M; Chung S; Shelness GS; Parks JS Biochim Biophys Acta; 2012 May; 1821(5):770-7. PubMed ID: 22001232 [TBL] [Abstract][Full Text] [Related]
17. Identification of Ets-1 as an important transcriptional activator of CTP:phosphocholine cytidylyltransferase alpha in COS-7 cells and co-activation with transcriptional enhancer factor-4. Sugimoto H; Sugimoto S; Tatei K; Obinata H; Bakovic M; Izumi T; Vance DE J Biol Chem; 2003 May; 278(22):19716-22. PubMed ID: 12642588 [TBL] [Abstract][Full Text] [Related]
18. Role of plasma and liver cholesterol- and lipoprotein-metabolism determinants in LpX formation in the mouse. Bravo I; Amigo L; Cohen DE; Nervi F; Rigotti A; Francone O; Zanlungo S Biochim Biophys Acta; 2007 Jun; 1770(6):979-88. PubMed ID: 17399905 [TBL] [Abstract][Full Text] [Related]
19. Phosphorylation of Sp1 by cyclin-dependent kinase 2 modulates the role of Sp1 in CTP:phosphocholine cytidylyltransferase alpha regulation during the S phase of the cell cycle. Banchio C; Schang LM; Vance DE J Biol Chem; 2004 Sep; 279(38):40220-6. PubMed ID: 15247247 [TBL] [Abstract][Full Text] [Related]
20. Substitutions of glutamate 110 and 111 in the middle helix 4 of human apolipoprotein A-I (apoA-I) by alanine affect the structure and in vitro functions of apoA-I and induce severe hypertriglyceridemia in apoA-I-deficient mice. Chroni A; Kan HY; Kypreos KE; Gorshkova IN; Shkodrani A; Zannis VI Biochemistry; 2004 Aug; 43(32):10442-57. PubMed ID: 15301543 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]